Catherine A. Sohn

Companies

• Maze Therapeutics, Inc.Board member Jan 30, 2025 to now¹
• Altimmune, Inc.Board member Mar 27, 2023 to now²
• Jazz PharmaceuticalsBoard member Aug 2, 2012 to Aug 15, 2023³
• LIFECORE BIOMEDICAL, INC. \DE\Board member Nov 20, 2012 to Jun 7, 2022⁴
• Axcella Health (United States)Board member Aug 23, 2019 to May 23, 2022⁵
• Rubius Therapeutics (United States)Board member Jul 17, 2018 to May 13, 2022⁶
• PALISADE BIO, INC.Board member Jul 31, 2014 to Jul 6, 2015⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• JPJazz Pharmaceuticals JAZZ14,868 shares⁸$3.1M at $207.05Aug 14, 2023
• LBLIFECORE BIOMEDICAL, INC. \DE\ LFCR54,069 shares⁹$346.6K at $6.41Jun 4, 2022
• AAltimmune, Inc. ALT1,500 shares¹⁰$3.5K at $2.32Jan 5, 2026
• MTMaze Therapeutics, Inc. MAZE0 shares¹¹Jan 7, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 7, 2026Sold 26,920 shares at $39.11 of Maze Therapeutics, Inc.¹¹
• Jan 7, 2026Exercised options 3,281 shares at $10.42 of Maze Therapeutics, Inc.¹¹
• Jan 7, 2026Exercised options 2,895 shares at $10.42 of Maze Therapeutics, Inc.¹¹
• Jan 7, 2026Exercised options 20,744 shares at $10.42 of Maze Therapeutics, Inc.¹¹
• Jan 6, 2026Sold 2,493 shares at $38.62 of Maze Therapeutics, Inc.¹¹
• Jan 6, 2026Exercised options 2,493 shares at $10.42 of Maze Therapeutics, Inc.¹¹
• Jan 5, 2026Bought 500 shares at $4.24 of Altimmune, Inc.¹⁰
• Mar 17, 2025Bought 1,000 shares at $5.78 of Altimmune, Inc.¹²
• Aug 14, 2023Sold 1,241 shares at $138.16 of Jazz Pharmaceuticals⁸
• Aug 11, 2023Granted 3,075 shares of Jazz Pharmaceuticals⁸
• Aug 8, 2022Sold 1,089 shares at $152.32 of Jazz Pharmaceuticals¹³
• Aug 5, 2022Granted 2,561 shares of Jazz Pharmaceuticals¹³
• Jun 4, 2022Granted 7,059 shares at $9.50 of LIFECORE BIOMEDICAL, INC. \DE\⁹